Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Empagliflozin vs Metformin in PCOS
NCT03008551Phase 3Completed
- Sponsor
- Hull University Teaching Hospitals
- Start
- Aug 2017
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of empagliflozin in polycystic ovary syndrome (PCOS), sponsored by Hull University Teaching Hospitals. Started Aug 2017; status: completed.
02
Drugs
empagliflozin
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT03008551.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03008551.